Page last updated: 2024-10-26

dipyridamole and Anasarca

dipyridamole has been researched along with Anasarca in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwakoshi, H1
Nakayama, T1
Hirata, N1
Sakata, T1
Sakamoto, T1
Sugimoto, M1
Anto, M1
Araki, T1
Koga, K1
Yamamoto, O1

Other Studies

1 other study available for dipyridamole and Anasarca

ArticleYear
[A case of thrombotic thrombocytopenic purpura with prominent whole body edema and choroidal detachment].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Jun-10, Volume: 81, Issue:6

    Topics: Adult; Choroid Diseases; Dipyridamole; Edema; Female; Humans; Plasma Exchange; Purpura, Thrombotic T

1992